Labetalol tablet dosage forms and strengths: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Labetalol}} | |||
{{CMG}}; {{AE}} {{SS}} | |||
==dosage forms and strengths== | |||
{| | |||
|- | |||
|[[File:Labetalol02.jpg|thumb|800px]] | |||
|- | |||
|} | |||
{| | |||
|- | |||
|[[File:Labetalol04.jpg|thumb|800px]] | |||
|- | |||
|} | |||
{| | |||
|- | |||
|[[File:Labetalol03.jpg|thumb|800px]] | |||
|- | |||
|}<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LABETALOL HYDROCHLORIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5b65a9b-6b8a-48a4-9c72-0e605bb309eb | publisher = | date = | accessdate = 5 February 2014 }}</ref> |
Revision as of 17:53, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
dosage forms and strengths
- ↑ "LABETALOL HYDROCHLORIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.]". Retrieved 5 February 2014.